D. Boral Capital believes Anavex’s Alzheimer’s treatment is superior to Cassava Sciences' approach.
Rambus’ technology and IP is central to the artificial intelligence-driven performance increase in data centers, said Baird analyst Tristan Gerra.
Revenue declined over 3% year-over-year (YoY) to $9.445 billion compared to an analyst estimate of $9.63 billion.
The CEO also highlighted the recent divestiture of the Voortman business, a strategic move to prioritize its largest growth opportunities.
Amgen’s weight-loss drug candidate MariTide is meant to be administered subcutaneously monthly or less frequently in obese or overweight patients without Type 2 diabetes.
Chairman and CEO Chris Pavlovski said the world is still in the early stages of the adoption of Bitcoin, which has recently accelerated with the election of a crypto-friendly U.S. presidential administration and increased institutional adoption.
The global licensing deal includes $500 million in cash and $325 million in equity, at a 35% premium upon closing.
The grant comes with several terms and conditions, including Intel agreeing to pause stock buybacks for five years.
Retail veteran Ashley Buchanan, has held various executive roles at Michaels Companies, Walmart, Sam's Club, Dell and Accenture, will be taking over the leadership role.
The new proposal would expand access to medications for obesity, and help an estimated 3.4 million Americans with Medicare.
